Influence of Usnic Acid and its Derivatives on the Activity of Mammalian Poly(ADP-ribose)polymerase 1 and DNA Polymerase β

被引：12
|
作者：
Zakharenko, Alexandra [2 ]
Sokolov, Dmitry [1 ]
Luzina, Olga [1 ]
Sukhanova, Maria [2 ]
Khodyreva, Svetlana [2 ]
Zakharova, Olga [2 ]
Salakhutdinov, Nariman [1 ]
Lavrik, Olga [2 ]
机构：
[1] Russian Acad Sci, Siberian Branch, NN Vorozhtsov Novosibirsk Inst Organ Chem, Novosibirsk 630090, Russia
[2] Russian Acad Sci, Siberian Branch, Novosibirsk Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia
来源：
MEDICINAL CHEMISTRY | 2012年 / 8卷 / 05期
关键词：
DNA Polymerase beta; PARP1; Poly(ADP-ribose)polymerase; Usnic acid; NITRIC-OXIDE SYNTHASE; HUMAN CANCER-CELLS; (+)-USNIC ACID; CHEMICAL-MODIFICATION; CYTOTOXIC ACTIVITY; DIFFRACTAIC ACID; LICHEN COMPOUNDS; IN-VITRO; REPAIR; EXCISION;
D O I：
10.2174/157340612802084225
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The influence of a number of usnic acid derivatives on auto(polyADP-ribosyl)ation catalyzed by PARP1 and DNA synthesis catalyzed by DNA polymerase beta was studied. The derivatives of usnic acid containing aromatic substituents were shown to be moderate inhibitors of PARP1. The presence of both usnic acid tricyclic structure and aromatic substituent at any position of the molecule is a key factor for the inhibitory action. In the case of DNA polymerase, no relationship between the structure and inhibitory properties has been found with the only exception. Derivatives with modified ring A showed mild activation of DNA synthesis catalyzed by DNA polymerase beta.
引用
收藏
页码：883 / 893
页数：11
相关论文
共 50 条
  • [31] Inhibition of the activity of poly (ADP-ribose) polymerase in hemorrhagic shock
    McDonald, MC
    Mota-Filipe, H
    Abdelrahman, M
    Threadgill, M
    Thiemermann, C
    SHOCK, 2004, 21 : 91 - 91
  • [32] Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
    Jagtap, P
    Szabó, C
    NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (05) : 421 - 440
  • [33] Targeting poly(ADP-ribose) polymerase activity for cancer therapy
    Frédérique Mégnin-Chanet
    Marc A. Bollet
    Janet Hall
    Cellular and Molecular Life Sciences, 2010, 67 : 3649 - 3662
  • [34] Targeting poly(ADP-ribose) polymerase activity for cancer therapy
    Megnin-Chanet, Frederique
    Bollet, Marc A.
    Hall, Janet
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (21) : 3649 - 3662
  • [35] Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity
    Sun, Shuya
    Hu, Yuehuai
    Zheng, Qiyao
    Guo, Zhen
    Sun, Duanping
    Chen, Shaorui
    Zhang, Yiqiang
    Liu, Peiqing
    Lu, Jing
    Jiang, Jianmin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 4813 - 4826
  • [36] Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
    Prakash Jagtap
    Csaba Szabó
    Nature Reviews Drug Discovery, 2005, 4 : 421 - 440
  • [37] Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium
    Cooper, Karen L.
    Dashner, Erica J.
    Tsosie, Ranalda
    Cho, Young Mi
    Lewis, Johnnye
    Hudson, Laurie G.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 291 : 13 - 20
  • [38] Enzymatic and domain-specific interactions of poly(ADP-ribose) polymerase-1 with DNA polymerase β
    Alvarez-Gonzalez, R
    Confer, NF
    Kumari, SR
    FASEB JOURNAL, 2005, 19 (04): : A858 - A858
  • [39] MECHANISMS OF POLY(ADP-RIBOSE) POLYMERASE CATALYSIS - MONO-ADP-RIBOSYLATION OF POLY(ADP-RIBOSE) POLYMERASE AT NANOMOLAR CONCENTRATIONS OF NAD
    BAUER, PI
    HAKAM, A
    KUN, E
    FEBS LETTERS, 1986, 195 (1-2) : 331 - 338
  • [40] STRUCTURE AND FUNCTION OF POLY(ADP-RIBOSE) POLYMERASE
    DEMURCIA, G
    SCHREIBER, V
    MOLINETE, M
    SAULIER, B
    POCH, O
    MASSON, M
    NIEDERGANG, C
    DEMURCIA, JM
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1994, 138 (1-2) : 15 - 24
12345